How do you reach the three million people who become ill with tuberculosis every year, but go undetected, suffering and dying needlessly, while infecting others? The answer is simple: take a risk. TB REACH, a program of the Stop TB Partnership, has embraced the “inherent risk of innovation” to find new, more effective approaches to […]
Rep. Barbara Lee: “When it comes to saving lives PEPFAR is a clear example of how we come together to do just that” By the time the House of Representatives began to take up the PEPFAR Stewardship and Oversight Act of 2013 Tuesday afternoon, the end was not in doubt. All the same, once lawmakers […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
When provinces in Canada lifted restrictions pegging eligibility for treatment for hepatitis C with direct-acting antivirals to the stage of the disease — or range of […]